CAMP: Complementary and Alternative Medicine Interventions in Targeting Pain

Sponsor
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria (Other)
Overall Status
Completed
CT.gov ID
NCT04845334
Collaborator
Scuola di Specializzazione in Psicologia Clinica dell'Università degli Studi di Torino (Other), Fondazione CRT (Other)
128
2
29

Study Details

Study Description

Brief Summary

This Controlled Randomized Clinical Trial aimed at determining the effectiveness of a modified RR intervention in reducing post-operative pain and psychological symptoms in patients undergoing surgery intervention.

Researches hypothesized that compared to controls patients undergoing modified RR intervention were characterized by

  1. improved capability to discriminate emotions from bodily feelings;

  2. reduce emotional distress;

  3. reduced pain perception.

Moreover, researches hypothesized that (4) these effects were maintained over time.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: RR intervention
N/A

Detailed Description

A Controlled Randomized Clinical Trial of a RR intervention for surgical patients was conducted in the SS. Antonio e Biagio e Cesare Arrigo Hospital, Alessandria, Italy.

Fifty-six patients were treated with the clinical RR intervention, while 62 patients were recruited as controls.

Variables were assessed through an ad hoc questionnaire and a pool of self-report questionnaires validated for the Italian population: the Toronto Alexithymia Scale (TAS-20), the Hospital Anxiety and Depression Scale (HADS), the Impact of Event Scale - Revised (IES-R), the Numeric Rating Scale (NRS), and the Emotion Thermometer (ET).

The TAS-20 is a frequently used 20-items self-report measure of alexithymia. A score ≥ 61 is considered to be indicative of alexithymia, whereas scores between 51 and 60 indicate borderline alexithymia. It has a 3-factor structure: Difficulty in Identifying Feelings (TAS-DIF); Difficulty in Describing Feelings (TAS-DDF), and Externally Oriented Thinking (TAS-EOT).

The HADS is a brief, reliable self-report measure used to assess anxiety and depression in hospitalized and ambulatory medical patients, as well as in primary care and research. It consists of 7 items for anxiety (HADS-A) and 7 for depression (HADS-D). Scores > 8 in each subscale are indicative of clinically relevant anxiety and depression, respectively.

The IES-R is a widely used 22-items self-report measure of subjective distress caused by traumatic events. It considers three independent dimensions: intrusion, avoidance, and hyper-arousal.

The NRS is a unidimensional measure of pain intensity in adults. It is a segmented numeric version of the visual analog scale (VAS), in which respondents select the number (0-10 integers) that best reflects the intensity of their pain. The common format is a horizontal bar or line.

The ET is a simple, self-report measure of four emotion domains (distress, anxiety, depression, and anger) and one non-emotion domain (need for help). Respondents have to rate each dimension on a vertical visual analogue scale (thermometer), with the anchors 0 and 10, to indicate which level of distress they experienced over the previous week.

Outcome measures were administered at 4 time-points:

T0: Baseline (3 months before the surgical intervention).

  • Baseline alexithymia levels assessed with the TAS-20;

  • baseline anxiety and depression levels assessed with the HADS;

  • baseline post-traumatic distress assessed with the IES-R;

  • baseline pain intensity assessed with the NRS;

  • baseline psychological distress assessed with the ET;

  • baseline use of analgesic drugs assessed with an ad hoc question.

T1: The morning before the surgical intervention.

  • Changes in alexithymia levels assessed with the TAS-20;

  • changes in anxiety and depression levels assessed with the HADS;

  • changes in post-traumatic distress assessed with the IES-R;

  • changes in pain intensity assessed with the NRS;

  • changes in psychological distress assessed with the ET;

  • changes in use of analgesic drugs assessed with an ad hoc question.

T2: At discharge, assessed up to 10 days.

  • Changes in alexithymia levels assessed with the TAS-20;

  • changes in anxiety and depression levels assessed with the HADS;

  • changes in post-traumatic distress assessed with the IES-R;

  • changes in pain intensity assessed with the NRS;

  • changes in psychological distress assessed with the ET;

  • changes in use of analgesic drugs assessed with an ad hoc question.

T3: 3 months after the surgical intervention.

  • Changes in alexithymia levels assessed with the TAS-20;

  • changes in anxiety and depression levels assessed with the HADS;

  • changes in post-traumatic distress assessed with the IES-R;

  • changes in pain intensity assessed with the NRS;

  • changes in psychological distress assessed with the ET;

  • changes in use of analgesic drugs assessed with an ad hoc question.

Subjects in the RR group underwent the clinical interventions between T0 and T1, while the controls underwent standard care.

Ethics

The study was reviewed and approved by the Institutional Review Board (IRB) of the SS. Antonio e Biagio e Cesare Arrigo Hospital, Alessandria, Italy. All participants gave informed written consent before entering the study. All research procedures were conducted in accordance with the ethical standards of the committees responsible for human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008.

Participants

Patients were recruited between January 2015 and June 2017.

Patients in the Departments of Vascular Surgery, General Surgery and Neurosurgery were included, considering their similarities for what concerns surgical impact, recovery, and post-recovery expectation. Expected surgical patients in the recruitment period were computed considering the prevalent frequency of each specific intervention in every Department:

  • General Surgery: patients scheduled for right hemicolectomies (60 patients/years expected), quadrantectomies (80 patients/years expected);

  • Neurosurgery: patient scheduled for spinal fusion with non-traumatic etiology (225 patients/years expected)

  • Vascular Surgery: patient scheduled for carotid stenosis or abdominal aortic aneurysm (205 patients/years expected).

With an expected population of 570 surgical patients in the recruitment period, an a priori power analysis conducted with G*Power (Faul et al., 2007) indicated that a total sample size of 82 participants was required (α = 0.05; 1-β = 0.80; d = 0.25).

Randomization and blinding:

A block randomization method was used with block size of 4, stratified by age, gender and clinical conditions. A series of numbers was generated in advance using a computer program. Following completion of the baseline measures, a research assistant assigned a study group to each participant, following the series generated by the computers. This research assistant as well as the personnel involved in the RR inspired intervention were aware of the patient-group assignment. Remaining study personnel were blind to subject's group assignment. In addition, for blinded purposes, the study participants were instructed not to discuss the intervention with anyone.

Study Design

Study Type:
Interventional
Actual Enrollment :
128 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Complementary and Alternative Medicine Interventions in Targeting Pain
Actual Study Start Date :
Jan 1, 2015
Actual Primary Completion Date :
Jun 1, 2017
Actual Study Completion Date :
Jun 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: Clinical RR intervention

Clinical RR intervention

Behavioral: RR intervention
The short psychological intervention consists of a narrative interview and a psychocorporeal intervention. Narrative interview: this is an interview aimed at exploring the experience and awareness of illness. The sharing of the dimension of pain and suffering, the verbalization of emotions, the narration of the history of illness, expectations and fears related to the intervention will be aimed at an emotional and cognitive restructuring of the experience of illness, improving the perception of internal resources and resilience. Psycho-corporeal intervention:it is a training to the psychophysiological technique of the "Relaxation Response" (R.R.) of Hebert Benson (Mind-Body Medical Institute of Havard), aimed at stress management and consequently at reducing the perception of pain

No Intervention: Standard care

Standard care

Outcome Measures

Primary Outcome Measures

  1. Changes in alexithymia (TAS scores) following a specific short psycho-corporeal intervention [Baseline; The morning before the surgical intervention; At discharge, assessed up to 10 days; 3 months after the surgical intervention]

    Changes in the Toronto Alexithymia Scale (TAS-20) scores following a specific short psychocorporeal intervention Total score. Range: 20-100. Higher scores mean a worse outcome. Difficulty in Identifying Feelings (TAS-DIF). Range: 7-35. Higher scores mean a worse outcome. Difficulty in Describing Feelings (TAS-DDF). Range: 5-25. Higher scores mean a worse outcome. Externally Oriented Thinking (TAS-EOT). Range: 8-40. Higher scores mean a worse outcome.

  2. Changes in anxiety and depression (HADS scores) following a specific short psycho-corporeal intervention [[Time Frame: Baseline; The morning before the surgical intervention; At discharge from the hospital, up to 10 days after the intervention; 3 months after the surgical intervention]]

    Changes in the Hospital Anxiety and Depression Scale (HADS) scores following a specific short psycho-corporeal intervention. Anxiety score. Range: 0-21. Higher scores mean a worse outcome. Depression score. Range: 0-21. Higher scores mean a worse outcome.

  3. Changes in post-traumatic distress (IES-R scores) following a specific short psycho-corporeal intervention [[Time Frame: Baseline; The morning before the surgical intervention; At discharge from the hospital, up to 10 days after the intervention; 3 months after the surgical intervention]]

    Changes in the Impact of Event Scale - Revised (IES-R) scores following a specific short psycho-corporeal intervention Total score. Range: 0-88. Higher scores mean a worse outcome. Hyperarousal subscale. Range: 0-4. Higher scores mean a worse outcome. Avoidance subscale. Range: 0-4. Higher scores mean a worse outcome. Intrusion subscale. Range: 0-4. Higher scores mean a worse outcome.

  4. Changes in pain intensity perception (NRS scores) following a specific short psycho-corporeal intervention [[Time Frame: Baseline; The morning before the surgical intervention; At discharge from the hospital, up to 10 days after the intervention; 3 months after the surgical intervention]]

    Changes in the Numeric Rating Scale (NRS) scores following a specific short psycho-corporeal intervention • Total score. Range: 0-10. Higher scores mean a worse outcome.

  5. Changes in psychological distress (ET scores) following a specific short psycho-corporeal intervention [[Time Frame: Baseline; The morning before the surgical intervention; At discharge from the hospital, up to 10 days after the intervention; 3 months after the surgical intervention]]

    Changes in the Emotion Thermometer (ET) scores following a specific short psycho-corporeal intervention Distress scale. Range: 0-10. Higher scores mean a worse outcome. Anxiety scale. Range: 0-10. Higher scores mean a worse outcome. Depression scale. Range: 0-10. Higher scores mean a worse outcome. Anger scale. Range: 0-10. Higher scores mean a worse outcome. Need for help scale. Range: 0-10. Higher scores mean a worse outcome.

Secondary Outcome Measures

  1. Effectiveness of the short psycho-corporeal intervention in reducing the use of analgesic drugs. [[Time Frame: Baseline; The morning before the surgical intervention; At discharge from the hospital, up to 10 days after the intervention; 3 months after the surgical intervention]]

    Effectiveness of the short psycho-corporeal intervention in reducing the use of analgesic drugs

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • patients waiting for a surgical intervention in the Departments of Vascular Surgery, General Surgery and Neurosurgery;

  • age ≥ 18 years.

Exclusion Criteria:
  • having a poor knowledge of the Italian language;

  • having a cognitive impairment;

  • having a certified psychiatric diagnosis;

  • having a certified diagnosis of a neurodegenerative disease (i.e., Alzheimer disease, Parkinson disease, etc.)

  • having been in psychiatric or psychological therapy in the last 6 months

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
  • Scuola di Specializzazione in Psicologia Clinica dell'Università degli Studi di Torino
  • Fondazione CRT

Investigators

  • Study Director: Antonella Granieri, Professor, Dipartimento di Psicologia dell'Università degli Studi di Torino
  • Study Director: Fanny Guglielmucci, PhD, Dipartimento di Psicologia dell'Università degli Studi di Torino

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
ClinicalTrials.gov Identifier:
NCT04845334
Other Study ID Numbers:
  • ASO.Psg.15.01
First Posted:
Apr 14, 2021
Last Update Posted:
Jul 28, 2021
Last Verified:
Jul 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 28, 2021